The Annex 1 of the EU GMP Guide "Manufacture of Sterile Medicinal Products" is considered the most important European regulatory standard for the…
CPhI Worldwide 2021 will combine the world’s leading pharma companies, incredible speakers and unparalleled networking opportunities.
It is the place, where leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies come together and build…
Together our teams are breaking new ground in small batch filling. Learn more about this award-winning collaboration.
The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company.
Vetter's Contribution to Climate Protection
Small filling runs create unique challenges. See how Vetter and Syntegon are combining their expertise to solve them
How Global Trends Are Driving Patient-Centricity in Parenteral Products.
After only one year our location in Austria has been modified to the high Vetter quality standards.
The key to successful development and guiding a drug to approval is early planning.
Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.
92 percent of our colleagues in Chicago named Vetter a “Great Place to Work” company!